Back to search
Psychosis; Episode
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Psychosis; Episode trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Psychosis; Episode trials you may qualify forThis proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinic…
The project aims to explore changes in brain chemistry in individuals who have recently experienced psychosis. Recent research suggests that chemicals in the br…
Young people constitute nearly half of Pakistan's population and are highly vulnerable to risk factors for mental illness, including poverty, inequality, abuse,…
The aim of this study is to investigate the role of the immune system in psychotic symptoms and their response to treatment. The investigators will collect bloo…
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disor…
This proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinic…
This will be a randomized, placebo-controlled, parallel-group, multi-site, double-blind trial of elpipodect compared with placebo, using Risperidone as an activ…
The purpose of this study was to evaluate the efficacy and safety of elpipodect at a range of doses (8 mg, 16 mg, and 24 mg once daily \[QD\]) in adult particip…